CRXTQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CRXTQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Clarus Therapeutics Holdings has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Clarus Therapeutics Holdings's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Thomas Mcnerney & Partners Lp | 10 percent owner | 45 S. 7TH ST., SUITE 3060, MINNEAPOLIS MN 55402 |
Kimberly M Murphy | director | 101 EAST KENNEDY BLVD., SUITE 2800, TAMPA FL 33602 |
Elizabeth Cermak | director | 1414 RALEIGH ROAD, SUITE 400, CHAPEL HILL NC 27517 |
Prygocki Mark A Sr | director | C/O MEDICS, 8125 N. HAYDEN RD, SCOTTSDALE AZ 85258 |
John Kenneth Amory | director | C/O CLARUS THERAPEUTICS HOLDINGS, INC., 555 SKOKIE BLVD, SUITE 340, NORTHBROOK IL 60662 |
Robert E. Dudley | director, officer: Chief Executive Officer | 555 SKOKIE BOULEVARD, SUITE 340, NORTHBROOK IL 60062 |
Joseph Hernandez | director | C/O MICROLIN BIO, INC., NEW YORK NY 10022 |
Richard D Peterson | officer: Chief Financial Officer | 1110 WEST COMMERCIAL BOULEVARD, FORT LAUDERDALE FL 33309 |
Frank Jaeger | officer: Chief Commercial Officer | CLARUS THERAPEUTICS HOLDINGS, INC., 555 SKOKIE BLVD, SUITE 340, NORTHBROOK IL 60662 |
Steven A. Bourne | officer: Chief Administrative Officer | 555 SKOKIE BOULEVARD, SUITE 340, NORTHBROOK IL 60062 |
Ffi Fund Ltd | 10 percent owner | DMS HOUSE, 20 GENESIS CLOSE, GRAND CAYMAN, GEORGE TOWN E9 KY1-1208 |
Thomas, Mcnerney & Partners Ii L.p. | 10 percent owner | 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402 |
Thomas, Mcnerney & Partners Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Tmp Nominee Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Tmp Associates Ii Lp | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-01-2022
By GuruFocusNews GuruFocusNews • 06-28-2022
By GuruFocusNews GuruFocusNews • 06-19-2022
By GuruFocusNews GuruFocusNews • 06-09-2022
By GuruFocusNews GuruFocusNews • 06-29-2022
By GuruFocusNews GuruFocusNews • 06-05-2022
By GuruFocusNews GuruFocusNews • 05-29-2022
By GuruFocusNews GuruFocusNews • 07-09-2022
By GuruFocusNews GuruFocusNews • 06-01-2022
By GuruFocusNews GuruFocusNews • 06-08-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.